Invention Grant
- Patent Title: Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof
-
Application No.: US15146868Application Date: 2016-05-04
-
Publication No.: US10233244B2Publication Date: 2019-03-19
- Inventor: Jason Gary Sagert , Jonathan Alexander Terrett , Luc Roland Desnoyers , Shweta Singh , Annie Yang Weaver
- Applicant: CytomX Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: CytomX Therapeutics, Inc.
- Current Assignee: CytomX Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Cooley LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/46 ; C07K16/28 ; C07K7/08 ; A61K47/68 ; C07K16/30 ; A61K39/00
Abstract:
The invention relates generally to antibodies that bind ITGa3, activatable antibodies that specifically bind to ITGa3 and methods of making and using these anti-ITGa3 antibodies and anti-ITGa3 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Public/Granted literature
- US20160355592A1 ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHODS OF USE THEREOF Public/Granted day:2016-12-08
Information query
